BRPI0517024A - conjugados com atividade antiinflamatória - Google Patents

conjugados com atividade antiinflamatória

Info

Publication number
BRPI0517024A
BRPI0517024A BRPI0517024-9A BRPI0517024A BRPI0517024A BR PI0517024 A BRPI0517024 A BR PI0517024A BR PI0517024 A BRPI0517024 A BR PI0517024A BR PI0517024 A BRPI0517024 A BR PI0517024A
Authority
BR
Brazil
Prior art keywords
inflammatory activity
steroid
xiii
nonsteroidal
substructure
Prior art date
Application number
BRPI0517024-9A
Other languages
English (en)
Inventor
Mladen Mercep
Milan Mesic
Linda Tomaskovic
Stribor Markovic
Visnja Poljak
Gordana Sijan
Selvira Selmani
Original Assignee
Glaxosmithkline Zagreb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Zagreb filed Critical Glaxosmithkline Zagreb
Publication of BRPI0517024A publication Critical patent/BRPI0517024A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

CONJUGADOS COM ATIVIDADE ANTIINFLAMATóRIA A presente invenção refere-se a novos Compostos representados pela Fórmula I: onde M representa uma subunidade macrolida da subestrutura VIII: L representa a cadeia da subestrutura IX ou XIII: Z representa a subunidade esteróide ou não esteroidal derivada de drogas esteróides ou não esteroidais (NSAID) com atividade antiinflamatória. A presente invenção refere-se ainda aos sais farmaceuticamente aceitáveis e solvatos de tais Compostos preparados, a processos e intermediários para sua preparação, bem como a ação terapêutica melhorada e ao uso no tratamento de doenças e condições inflamatórias em humanos e animais.
BRPI0517024-9A 2004-10-27 2005-10-27 conjugados com atividade antiinflamatória BRPI0517024A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62315404P 2004-10-27 2004-10-27
PCT/IB2005/003213 WO2006046123A2 (en) 2004-10-27 2005-10-27 Conjugates with anti-inflammatory activity

Publications (1)

Publication Number Publication Date
BRPI0517024A true BRPI0517024A (pt) 2008-03-25

Family

ID=36097295

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0517024-9A BRPI0517024A (pt) 2004-10-27 2005-10-27 conjugados com atividade antiinflamatória

Country Status (17)

Country Link
US (1) US20090048221A1 (pt)
EP (2) EP1805202B1 (pt)
JP (1) JP2008517993A (pt)
KR (1) KR20070083811A (pt)
CN (1) CN101090908A (pt)
AT (1) ATE453658T1 (pt)
AU (1) AU2005298312A1 (pt)
BR (1) BRPI0517024A (pt)
CA (1) CA2585711A1 (pt)
DE (1) DE602005018672D1 (pt)
ES (1) ES2337915T3 (pt)
IL (1) IL182694A0 (pt)
MX (1) MX2007005073A (pt)
NO (1) NO20072684L (pt)
RU (1) RU2007119577A (pt)
WO (1) WO2006046123A2 (pt)
ZA (1) ZA200702579B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2337915T3 (es) * 2004-10-27 2010-04-30 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Conjugados con adtividad antiinflamatoria.
FR2909876A1 (fr) * 2006-12-19 2008-06-20 Galderma Res & Dev S N C Snc Utilisation du nepafenac ou ses derives pour le traitement de desordres dermatologiques
CN101708338B (zh) * 2008-12-26 2014-06-04 中国人民解放军军事医学科学院放射与辐射医学研究所 含甾体结构的前药及其高度分散制剂
KR101245078B1 (ko) * 2010-11-11 2013-03-18 부산대학교 산학협력단 대장 선택성 셀레콕시브 전구체 화합물 및 이를 유효성분으로 함유하는 대장성 질환 치료 또는 예방용 약학조성물
US20160031925A1 (en) 2013-04-10 2016-02-04 Probiotic Pharmaceuticals Aps Azithromycin antimicrobial derivatives with non-antibiotic pharmaceutical effect
CN110799516A (zh) 2017-04-20 2020-02-14 来兴泰德基金会 作为抗癌剂的包含鏻离子的阿奇霉素衍生物
CA3060892A1 (en) 2017-04-20 2018-10-25 Rising Tide Foundation Azithromycin derivatives containing a phosphonium ion as anticancer agents
MY205435A (en) 2018-09-14 2024-10-21 Jiangyin Usun Pharmaceutical Co Ltd New conjugates of montelukast and peptides
CN111170959A (zh) * 2019-12-30 2020-05-19 南开大学 一种大环内酯化合物的晶型及其制备方法与用途
CN112521398B (zh) * 2020-07-30 2022-03-15 上海交通大学医学院附属仁济医院 一种海绵共附生菌来源开环重排甾体化合物及其制备方法与应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE76311T1 (de) 1986-08-19 1992-06-15 Genentech Inc Einrichtung und dispersion zum intrapulmonalen eingeben von polypeptidwuchsstoffen und zytokinen.
HU198913B (en) 1987-09-03 1989-12-28 Pliva Pharm & Chem Works Process for producing 10-dihydro-10-deoxo-11-aza-erythronolide a-derivatives and pharmaceutical compositions containing them as active components
SE9100341D0 (sv) 1991-02-04 1991-02-04 Astra Ab Novel steroids
SE9100342D0 (sv) 1991-02-04 1991-02-04 Astra Ab Novel steroid esters
GB9225923D0 (en) 1992-12-11 1993-02-03 Rhone Poulenc Rorer Ltd New compositions of matter
DE69311742T2 (de) 1992-12-24 1998-01-08 Rhone Poulenc Rorer Ltd Neue steroide
WO1996004919A1 (en) 1994-08-12 1996-02-22 Taisho Pharmaceutical Co., Ltd. Interleukin-5 production inhibitor
AU3192695A (en) 1994-08-12 1996-03-07 Taisho Pharmaceutical Co., Ltd. Interleukin-5 production inhibitor
DE19616573C2 (de) 1996-04-25 1999-03-04 Pari Gmbh Verwendung unterkritischer Treibmittelmischungen und Aerosole für die Mikronisierung von Arzneimitteln mit Hilfe dichter Gase
JP3530004B2 (ja) 1998-02-06 2004-05-24 株式会社日立ユニシアオートモティブ 吸入式投薬器
US6297260B1 (en) 1998-10-30 2001-10-02 Nitromed, Inc. Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
IT1306205B1 (it) 1999-01-15 2001-05-30 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
HRP20000310A2 (en) 2000-05-17 2002-02-28 Pliva Farmaceutska Ind Dioniko New dibenzoazulene compounds as tumor necrosis factor inhibitors
FI110835B (fi) 2000-07-11 2003-03-31 Radiolinja Ab Menetelmä palvelunumeropuhelun tarjoamiseksi matkaviestintilaajalle ennalta määrätyllä taksalla
HRP20010018A2 (en) 2001-01-09 2002-12-31 Pliva D D Novel anti-inflammatory compounds
AU2003219770B2 (en) 2002-02-15 2008-10-09 Merckle Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
RS20050008A (sr) 2002-07-08 2007-06-04 Pliva-Istraživački Institut D.O.O., Nova jedinjenja,kompozicije i metode za lečenje inflamatornih oboljenja i stanja
EP1521763A2 (en) 2002-07-08 2005-04-13 Pliva - Istrazivacki Institut d.o.o. Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use
AU2003264917A1 (en) * 2002-07-08 2004-01-23 Pliva - Istrazivacki Institut D.O.O. Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules
HRP20030324A2 (en) * 2003-04-24 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. Compounds of antiinflammatory effect
KR20070046917A (ko) * 2004-08-12 2007-05-03 글락소스미쓰클라인 이스트라지바치키 센타 자그레브 디.오.오. 위장관의 염증성 질환의 치료를 위한 세포-특이적컨쥬게이트의 용도
ES2337915T3 (es) * 2004-10-27 2010-04-30 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Conjugados con adtividad antiinflamatoria.

Also Published As

Publication number Publication date
WO2006046123A3 (en) 2006-07-06
EP2196469A1 (en) 2010-06-16
RU2007119577A (ru) 2008-12-10
MX2007005073A (es) 2007-06-25
ES2337915T3 (es) 2010-04-30
DE602005018672D1 (de) 2010-02-11
AU2005298312A1 (en) 2006-05-04
NO20072684L (no) 2007-07-11
CN101090908A (zh) 2007-12-19
KR20070083811A (ko) 2007-08-24
ZA200702579B (en) 2008-08-27
EP1805202B1 (en) 2009-12-30
US20090048221A1 (en) 2009-02-19
ATE453658T1 (de) 2010-01-15
CA2585711A1 (en) 2006-05-04
JP2008517993A (ja) 2008-05-29
WO2006046123A2 (en) 2006-05-04
IL182694A0 (en) 2007-09-20
EP1805202A2 (en) 2007-07-11

Similar Documents

Publication Publication Date Title
NO20072684L (no) Konjugater med anti-inflammatorisk aktivitet
GEP20084527B (en) Benzimidazolone compounds having 5-ht4 receptor agonistic activity
IL189191A0 (en) Thiazolyl piperidine derivatives useful as h3 receptor modulators
NO20071137L (no) Nye piperidinderivater for behandling av depresjon
ATE384058T1 (de) Thiazolderivate
TN2009000180A1 (en) NOVEL 1,4-BENZOTHIEPIN-l,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF
AR047529A1 (es) Compuestos de quinolina sustituidos
ATE512961T1 (de) Amorphes nebivolol hydrochlorid und seine herstellung
DE602005023197D1 (de) -muscarinrezeptors
WO2004094449A8 (en) Macrolide-conjugates with anti-inflammatory activity
GEP20084519B (en) 3-(4-heteroarylcyclo-hexylamino) cyclopenta-necarboxamides as modulators of chemokine receptors
NO20050571L (no) Nye ikke steroide anti-inflammatoriske substanser, sammensetninger og metoder for deres anvendelse
BR0208027A (pt) Composto de n-fenilarilsulfonamida, droga contendo o composto como ingrediente ativo, intermediário para o composto, e processos para a produção do mesmo
TW200626158A (en) Naphthaline derivatives
ATE495159T1 (de) Diaminocyclohexan- und diaminocyclopentanderivate
WO2007039462A3 (en) Indane derivatives as mch receptor antagonists
ATE466842T1 (de) 3-substituierte pyridinderivate als h3- antagonisten
NO20075209L (no) Substituerte aryl 1,4-pyrazinderivater
DE602006014305D1 (de) Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors
ATE449776T1 (de) Pyrroloä2,3-cüpyridinderivate
ATE412636T1 (de) Piperazinylpyridinderivate als mittel gegen adipositas
MX2009005242A (es) Derivados de 3-(hetero)arilisoquinolinamida sustituida en posición 5, 6 o 7 y uso terapeutico del mismo.
DE602006014022D1 (de) 5-substituierte indol-2-carbonsäureamidderivate
NO20065551L (no) Anvendelse av opoid reseptor antagonistforbindelser for forhindring og/eller behandling av sykdommer assosiert med malet calcineurin
TW200635592A (en) Pyridyl-substituted spiro-hydantoin compounds and use thereof

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.